[HTML][HTML] Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa

…, O Lesetedi-Mafoko, RJ Lessells, S Lockman… - Nature, 2022 - nature.com
The SARS-CoV-2 epidemic in southern Africa has been characterized by three distinct waves.
The first was associated with a mix of SARS-CoV-2 lineages, while the second and third …

[HTML][HTML] Antiretroviral regimens in pregnancy and breast-feeding in Botswana

…, A Ogwu, D Kitch, S Lockman… - … England Journal of …, 2010 - Mass Medical Soc
Background The most effective highly active antiretroviral therapy (HAART) to prevent
mother-to-child transmission of human immunodeficiency virus type 1 (HIV-1) in pregnancy and its …

Breastfeeding plus infant zidovudine prophylaxis for 6 months vs formula feeding plus infant zidovudine for 1 month to reduce mother-to-child HIV transmission in …

I Thior, S Lockman, LM Smeaton, RL Shapiro, C Wester… - Jama, 2006 - jamanetwork.com
ContextPostnatal transmission of human immunodeficiency virus-1 (HIV) via breastfeeding
reverses gains achieved by perinatal antiretroviral interventions.ObjectiveTo compare the …

Cigarette smoking and the risk of systemic lupus erythematosus: a meta‐analysis

…, DJ Kim, J Peerzada, S Lockman… - Arthritis & …, 2004 - Wiley Online Library
Objective Existing studies present conflicting evidence for the role of cigarette smoking as a
risk factor in the development of systemic lupus erythematosus (SLE). We performed an …

Highly active antiretroviral therapy and adverse birth outcomes among HIV-infected women in Botswana

…, N Parekh, A Ogwu, S Lockman… - The Journal of …, 2012 - academic.oup.com
Background. It is unknown whether adverse birth outcomes are associated with maternal
highly active antiretroviral therapy (HAART) in pregnancy, particularly in resource-limited …

[HTML][HTML] Response to antiretroviral therapy after a single, peripartum dose of nevirapine

S Lockman, RL Shapiro, LM Smeaton… - New England journal …, 2007 - Mass Medical Soc
Background A single dose of nevirapine during labor reduces perinatal transmission of
human immunodeficiency virus type 1 (HIV-1) but often leads to viral nevirapine resistance …

Neutralizing antibodies to adenovirus serotype 5 vaccine vectors are directed primarily against the adenovirus hexon protein

…, JHHV Custers, MM Addo, S Lockman… - The Journal of …, 2005 - journals.aai.org
The utility of recombinant adenovirus serotype 5 (rAd5) vector-based vaccines for HIV-1 and
other pathogens will likely be limited by the high prevalence of pre-existing Ad5-specific …

[HTML][HTML] Neural-tube defects and antiretroviral treatment regimens in Botswana

…, T Gaolathe, M Essex, S Lockman… - … England Journal of …, 2019 - Mass Medical Soc
Background A preliminary safety signal for neural-tube defects was previously reported in
association with dolutegravir exposure from the time of conception, which has affected choices …

Increased risk of preterm delivery among HIV-infected women randomized to protease versus nucleoside reverse transcriptase inhibitor-based HAART during …

…, A Ogwu, MD Hughes, S Lockman… - Journal of Infectious …, 2011 - academic.oup.com
Shahin Lockman , Shahin Lockman … Hughes, Shahin Lockman, Jean Leidner, Erik van
Widenfelt, Claire Moffat, Sikhulile Moyo, Joseph Makhema, Max Essex, Roger L. Shapiro, …

Botswana's progress toward achieving the 2020 UNAIDS 90-90-90 antiretroviral therapy and virological suppression goals: a population-based survey

…, EJT Tchetgen, V DeGruttola, M Essex, S Lockman - The lancet HIV, 2016 - thelancet.com
Background HIV programmes face challenges achieving high rates of HIV testing and treatment
needed to optimise health and to reduce transmission. We used data from the Botswana …